HUTCHMED Divests 45% Stake in Shanghai Hutchison Pharmaceuticals to GP Health Service Capital and Shanghai Pharmaceuticals Holding

Everstone Capital Acquires Controlling Stake in Softgel Healthcare

September 14, 2022

Pharmaceuticals

Everstone Capital has acquired a controlling (majority) stake in Softgel Healthcare Private Limited (SHPL), a Chennai-headquartered CDMO specializing in soft gelatin capsules and probiotics and part of the Madras Pharma Group. The investment will support SHPL's global expansion and capability development across pharmaceutical, nutraceutical and OTC markets, with Everstone partners joining the company's board.

SHS Invests in Develco Pharma

December 17, 2020

Pharmaceuticals

Tübingen-based SHS Gesellschaft für Beteiligungsmanagement mbH is making a minority growth investment from its SHS V fund in Swiss-German specialty drug company Develco Pharma. Develco, headquartered in Pratteln, Switzerland with ~125 employees and production in Schopfheim, Germany, develops and manufactures orally administered prolonged-release medicines and will use the investment to broaden its pipeline and expand capabilities.

SHS Capital and LPs Invest ~€10M in Develco Pharma

October 7, 2024

Pharmaceuticals

SHS Capital, together with its limited partners and other existing shareholders, is investing approximately €10 million in Develco Pharma to expand manufacturing capacity and accelerate product development in response to exceptionally strong demand. Develco, a specialty pharma developer and manufacturer of modified-release formulations headquartered in Pratteln (DACH region), has been backed by SHS since 2020 and reports an order book exceeding 12 months of revenue.

Hikma Pharmaceuticals Acquires Custopharm from Water Street Healthcare Partners

September 27, 2021

Pharmaceuticals

Hikma Pharmaceuticals has agreed to acquire Custopharm Inc., a US-based generic sterile injectables company, from Water Street Healthcare Partners for an initial $375 million plus up to $50 million in contingent consideration. The acquisition adds Custopharm's 13 approved products, R&D capabilities and pipeline to Hikma's injectables franchise and is expected to be accretive to Hikma's Injectables operating margin.

PureHealth Acquires 60% Stake in Hellenic Healthcare Group (HHG)

October 7, 2025

Healthcare Services

PureHealth Holding PJSC completed the acquisition of a 60% stake in Hellenic Healthcare Group (HHG) for EUR 800 million, implying a 100% equity valuation of EUR 1.3 billion. The deal brings HHG's 11 hospitals and 23 diagnostic centres (with over 6,900 healthcare professionals) into PureHealth's international healthcare platform, while CVC Capital Partners and HHG management retain a 40% stake.

CVC Capital Partners Acquires Majority Stake in Grupo GSH

April 16, 2025

Healthcare Services

CVC Capital Partners (Fund IX) will acquire a majority stake in Grupo GSH from Rede D’Or and Opus Investimentos, subject to regulatory approvals expected in Q3 2025. Grupo GSH, headquartered in Rio de Janeiro, is a leading Brazilian provider of hemotherapy (blood bank) and nuclear medicine/radiopharmacy services that serves hospitals and diagnostic centres across the country; CVC said it will support growth into new product categories and patient services.